Lexicon Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $274.2M
Liabilities Breakdown FY2013
Total Liabilities: $104.0M
Asset Breakdown
Total Assets: $274.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $37.5M | 13.7% |
| Accounts Receivable | $790.0K | 0.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $41.4M | 15.1% |
| Goodwill | $44.5M | 16.2% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $150.0M | 54.7% |
Liabilities Breakdown
Total Liabilities: $104.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.7M | 9.3% |
| Long-Term Debt | $20.2M | 19.4% |
| Other Liabilities | $74.1M | 71.3% |